Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.
about
The Intestinal Microbiota in Metabolic DiseaseProbiotics as Complementary Treatment for Metabolic DisordersNatural Dietary and Herbal Products in Anti-Obesity TreatmentSome current applications, limitations and future perspectives of lactic acid bacteria as probioticsProbiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and functionEffect of short-term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities.Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism in overweight and mildly obese individuals: a randomized controlled trial.Gut Endotoxin Leading to a Decline IN Gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese men.Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial.Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials.Dietary Alteration of the Gut Microbiome and Its Impact on Weight and Fat Mass: A Systematic Review and Meta-Analysis.
P2860
Q26750612-E31E640B-B318-4524-BC7B-E82120AA156AQ26795371-9A454B66-D869-4DB3-9DE7-FD0D1B28C33EQ28072291-94F42654-4405-44CE-96EF-DEA5EBF5EAF5Q33810967-4E44E0E1-9D83-449C-99AE-F3B1DC946564Q36181692-AA07CC3B-B02F-4BB8-8353-6F18D8597DCFQ36691129-DEED3B02-18A8-439E-BCBC-1E097A1BA7C8Q36819280-0036D161-F05D-4905-A2E8-7ED575CBB7BFQ36932845-F0D7219B-617B-4BBD-8346-5ED21429DCCCQ37031182-800F4B8F-9EBB-4461-8099-9D00718FBB0CQ37411378-18105678-967F-4D14-87A9-6A8728E3261EQ46279792-6E7D280E-1C25-4A57-A009-16ABE21D69F2Q47181222-D6B1476D-9A44-4CE1-92DE-34AF1305EECCQ51739338-86F032EA-5B3B-462C-A097-B29B8D996EEB
P2860
Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oral administration of Bifidob ...... a randomised controlled trial.
@ast
Oral administration of Bifidob ...... a randomised controlled trial.
@en
type
label
Oral administration of Bifidob ...... a randomised controlled trial.
@ast
Oral administration of Bifidob ...... a randomised controlled trial.
@en
prefLabel
Oral administration of Bifidob ...... a randomised controlled trial.
@ast
Oral administration of Bifidob ...... a randomised controlled trial.
@en
P2093
P2860
P356
P1476
Oral administration of Bifidob ...... a randomised controlled trial.
@en
P2093
Fumiaki Abe
Jin-Zhong Xiao
Jun-Ichi Minami
Naotake Yanagisawa
Sanae Saitoh
Shigeru Nakajima
Shizuki Kondo
Taeko Shimoda
Toshitaka Odamaki
Yukie Hamamoto
P2860
P356
10.1017/JNS.2015.5
P577
2015-05-04T00:00:00Z